Login to Your Account


HONG KONG – Established in February, South Korean biotech startup Bionetix Inc. has already secured a partnership with Southern Research to develop cancer drugs, and plans to move into the clinic with a lead program targeting glaucoma in 2019.

Considering that Chicago isn’t exactly a breeding ground for biopharma, Exicure Inc. already had defied expectations by raising more than $42 million since its inception in 2011 as Aurasense Therapeutics LLC and attracting the attention of tech and business notables such as Microsoft Corp. co-founder and philanthropist Bill Gates.

PERTH, Australia – Australian biotech Propanc Biopharma Inc. is advancing its lead product, PRP, toward the clinic in ovarian and pancreatic cancers.

More Newco News Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: